ExpreS2ion Biotech Holding AB (publ) 48,20
ExpreS2ion Biotech Holding AB (publ), through its subsidiary, ExpreS2 ion Biotechnologies ApS, develops, produces, and delivers therapeutics or diagnostic proteins in Denmark and internationally. It is also developing capsid virus-like particle COVID-19 vaccine; influenza vaccine; breast cancer vaccine; and malaria vaccine. In addition, the company licenses its ExpreS2 platform to research institutes and pharmaceutical companies. ExpreS2ion Biotech Holding AB (publ) was founded in 2015 is based in Horsholm, Denmark. Læs mere
Kr. 1,6B Markedsværdi
Kr. 14,6M Omsætning
Bioteknologi Industri
Sverige Hjemland